Nathan Rich
Stock Analyst at Goldman Sachs
(1.52)
# 3,122
Out of 4,765 analysts
89
Total ratings
36.51%
Success rate
-9.94%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $12.88 | +63.04% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $160.06 | +22.45% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $15.00 | +100.00% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $8.79 | -8.99% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $16.25 | +7.69% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $251.73 | +52.94% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $10.31 | +35.79% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $16.46 | -33.17% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $160.51 | +40.18% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $406.29 | +59.98% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $30 | $31.14 | -3.66% | 5 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $65.75 | +33.84% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $15.50 | -22.58% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $69.81 | +21.76% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $8.98 | +22.49% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $311.07 | +7.69% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $481.52 | +11.11% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $12.88
Upside: +63.04%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $160.06
Upside: +22.45%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $15.00
Upside: +100.00%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $8.79
Upside: -8.99%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $16.25
Upside: +7.69%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $251.73
Upside: +52.94%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $10.31
Upside: +35.79%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $16.46
Upside: -33.17%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $160.51
Upside: +40.18%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $406.29
Upside: +59.98%
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $31.14
Upside: -3.66%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $65.75
Upside: +33.84%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $15.50
Upside: -22.58%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $69.81
Upside: +21.76%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $8.98
Upside: +22.49%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $311.07
Upside: +7.69%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $481.52
Upside: +11.11%